Two major UK hospitals to deploy AI to help detect infections

Sanome has announced partnerships with The Royal Hospital for Neuro-disability and East Kent Hospitals University NHS Foundation Trust.

The firm’s MEMORI solution is an AI-powered clinical decision support tool that helps clinicians detect hospital-acquired infections (HAIs) earlier.

It analyses real-time patient data using explainable clinical AI to identify emerging infection risk, with early studies showing the potential to surface life-threatening HAI predictions up to three days earlier than standard practice.

The technology went live at The Royal Hospital for Neuro-disability in December 2025, with bedside go-live dates at East Kent Hospitals scheduled for the coming months and additional NHS deployments planned throughout 2026.

Benedikt von Thüngen, founder and chief executive of Sanome, said: “Partnering with leading healthcare organisations like the Royal Hospital for Neuro-disability and East Kent Hospitals University NHS Foundation Trust marks another major step towards bringing earlier, data-driven infection detection into everyday care for every patient.

“Working closely with clinicians, we’ve co-created a platform that not only flags those at risk but fits seamlessly into existing workflows.

“Our aim is to equip frontline teams with the actionable insights they need to intervene sooner and protect patients, at the same time relieving pressure on already-stretched resources.”

By flagging high-risk patients sooner and providing clear, actionable insights, the platform helps clinicians recognise deterioration and delver care earlier.

The tool is embedded directly within electronic patient records (EPRs), bringing these insights into clinicians’ existing workflows, which enables earlier decision-making.

Patients with complex neurological conditions are among the most vulnerable to infections and associated complications. Through integration with the PatientSource EPR, MEMORI will initially support earlier detection across four wards at the Royal Hospital for Neuro-disability.

East Kent Hospitals University NHS Foundation Trust is also partnering with Sanome to integrate real-time AI insights directly into its EPR system to support early recognition of deteriorating patients.

This collaboration lays the groundwork for a scalable new model for access to real-time NHS data, supporting thousands of patients across multiple hospital sites.

Mike Bedford, renal consultant and chief clinical information officer at East Kent Hospitals University NHS Foundation Trust, said: “Our population includes many older adults and individuals with multiple long-term health issues, so prevention and early detection are absolutely vital.

“By piloting tools like MEMORI, we’re proud to be one of the first NHS trusts to pioneer this type of technology sharing at the bedside, proving that data sharing is not only possible but transformative, as we aim to set a new standard for how the NHS can harness technology to improve care, reduce costs, and save lives.”

“Sanome’s ability to connect real-world evidence directly to bedside practice means ideas can move into clinical practice faster than ever before, an unprecedented step in an NHS system where therapies and technologies can otherwise take years to become part of the standard of care,” he added.

In August 2025, MEMORl was approved by the Medicines and Healthcare products Regulatory Agency and received EU Class IIb CE certification, paving the way for its rollout in the UK and Europe.